>>Plant Biology>> Plant Growth Regulators>>Sphynolactone-7

Sphynolactone-7 (Synonyms: SPL7)

Catalog No.GC48091

An agonist of S. hermonthica ShHTL7

Products are for research use only. Not for human use. We do not sell to patients.

Sphynolactone-7 Chemical Structure

Cas No.: 2305752-57-0

Size 가격 재고 수량
1 mg
US$43.00
재고 있음
5 mg
US$194.00
재고 있음
10 mg
US$342.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Sphynolactone-7 (SPL7) is an agonist of Striga hyposensitive to light receptor 7 (ShHTL7), which is found in the parasitic plant S. hermonthica.1 It selectively binds to ShHTL7 (IC50 = 0.31 µM) over ShHTL2-6, ShHTL9-10, and the strigolactone receptor AtD14 at 10 µM but does inhibit ShHTL8 and ShHTL11 (IC50s = 1.2 and 7.8 µM, respectively). SPL7 induces S. hermonthica seed germination in the absence of a host, which is fatal to this obligate parasite, with a minimum effective concentration of 10 fM. It induces suicidal germination of S. hermonthica seeds and decreases the number of plants emerging from the soil, as well as reduces S. hermonthica-induced senescence in maize plants when pre-applied to the soil of co-cultivated maize plants and S. hermonthica seeds at a concentration of 10 nM.

1.Uraguchi, D., Kuwata, K., Hijikata, Y., et al.A femtomolar-range suicide germination stimulant for the parasitic plant Striga hermonthicaScience362(6420)1301-1305(2018)

리뷰

Review for Sphynolactone-7

Average Rating: 5 ★★★★★ (Based on Reviews and 17 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Sphynolactone-7

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.